STOCK TITAN

Planned sale of 34,438 PTGX shares disclosed (NASDAQ: PTGX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of PTGX common stock has filed a notice of proposed sale under Rule 144. The filing covers 34,438 shares of common stock, to be sold through Morgan Stanley Smith Barney on the Nasdaq, with an indicated aggregate market value of $2,840,446.24. The filing notes that there were 62,515,666 shares of this class outstanding at the time of the notice.

The shares to be sold were acquired on 01/20/2026 through the vesting of restricted stock under a registered plan, with “services rendered” listed as the form of payment. The person for whose account the securities are to be sold represents that they do not know of any material adverse, non‑public information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many PTGX shares are planned to be sold under this Form 144?

The notice covers the proposed sale of 34,438 shares of PTGX common stock through a broker.

What is the indicated market value of the PTGX shares in this Form 144?

The filing reports an aggregate market value of $2,840,446.24 for the 34,438 PTGX common shares to be sold.

How and when were the PTGX shares in this Form 144 acquired?

The 34,438 common shares were acquired on 01/20/2026 through restricted stock vesting under a registered plan, with “services rendered” listed as the consideration.

On which exchange are the PTGX shares in this Form 144 expected to be sold?

The proposed sale is listed for execution on the Nasdaq securities exchange.

How many PTGX shares of this class were outstanding at the time of the notice?

The filing states that 62,515,666 shares of the relevant class of PTGX common stock were outstanding when the notice was prepared.

What does the signer of this PTGX Form 144 represent about non-public information?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Protagonist Ther

NASDAQ:PTGX

PTGX Rankings

PTGX Latest News

PTGX Latest SEC Filings

PTGX Stock Data

5.30B
60.63M
1.03%
116.23%
11.01%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEWARK